Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors
- 1 June 2002
- Vol. 59 (6) , 923-929
- https://doi.org/10.1016/s0090-4295(02)01528-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- RETROPERITONEAL LYMPH NODE DISSECTION FOR THE MANAGEMENT OF CLINICAL STAGE I NONSEMINOMAJournal of Urology, 2000
- RISK ADAPTED MANAGEMENT WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH RISK CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMORJournal of Urology, 2000
- Results and Outcome of Retroperitoneal Lymph Node Dissection for Clinical Stage I Embryonal Carcinoma–Predominant Testis CancerJournal of Clinical Oncology, 2000
- Complications of retroperitoneal lymph node dissection in testicular cancer: Primary and post-chemotherapySeminars in Surgical Oncology, 1999
- COMPLIANCE OF CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOR PATIENTS WITH SURVEILLANCEJournal of Urology, 1998
- CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria.American Journal of Roentgenology, 1997
- Testicular Germ-Cell CancerNew England Journal of Medicine, 1997
- Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A Non‐seminomatous Germ Cell Testis Cancer Review of the Indiana University Experience 1965–1989British Journal of Urology, 1993
- ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURSThe Lancet, 1982
- Non‐seminoma Germ Cell Tumours (Malignant Teratoma) of the Testis Results of Treatment and an Analysis of Prognostc Factors*British Journal of Urology, 1981